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ObesityObjective: It is clinically important to recognize how the underweight or obese affects electrocardiogram (ECG).
We assessed the effects of body mass index (BMI) on QRS axis or R-wave heights.
Methods: From daily outpatient electrocardiograms with sinus rhythm, 203 were selected. The patients were
classiﬁed into four groups: underweight (b18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight
(25–29.9 kg/m2) and obese (≥30 kg/m2).
Results:With increasing BMI, QRS axis shifted rightward to leftward. There was a signiﬁcant inverse correlation
between BMI and QRS axis (r =−0.60, p b 0.001). Multivariate linear regression analysis among age, female,
BMI, hypertension, left ventricular internal dimension and left ventricular mass (LVM) revealed that BMI was
an independent determinant of QRS axis (β= −0.52, p b 0.0001). Although LVM increased with increasing
BMI, R-wave heights in leads V4-5 were similar among the underweight, normal weight and overweight.
R-wave heights in leads V4-5 were signiﬁcantly lower paradoxically in the obese than other groups. With
increasing BMI, Sokolow–Lyon index corrected by LVM decreased progressively.
Conclusions: Our results suggest that the underweight or obese is strongly associated with QRS axis or R-wave
heights.
© 2015 TheAuthors. Published by Elsevier Ireland Ltd. This is an openaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The electrocardiogram (ECG) has been performed as a screening
test for detecting left ventricular hypertrophy (LVH) in patients
with hypertension because of its established clinical value, broad
availability and low cost [1,2]. Previous studies have shown that
ECG in the obese appears to have leftward shift of QRS axis and
low QRS voltage [3–6]. These studies assessed ECGs in the obese
and normal weight, and did not consider the underweight or
degrees of the obese. It is clinically important to recognize how
the underweight or obese affects ECG systematically. In the present
study, we assessed the effects of body mass index (BMI) on QRS
axis or R-wave heights. We also evaluated the effects of BMI on
the correlation between R-wave heights and left ventricular mass
(LVM) assessed by echocardiography.ku, Hiroshima 734–8551, Japan.
and Ltd. This is an open access article2. Methods
2.1. Patients
From daily outpatient electrocardiograms with sinus rhythm, 203
were selected. Patients with strain pattern suggesting LVHwere exclud-
ed because themain objective of this studywas to evaluate the effects of
BMI on the ECG. No patients were taking digitalis or antiarrhythmic
drugs. Patients with evidence of heart failure, previous myocardial
infarction, cardiomyopathy, interventricular conduction delay (QRS
duration N 120 ms) or chronic obstructive pulmonary disease were
excluded in this study [7]. Hypertension was deﬁned as systolic blood
pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg or use of
antihypertensive drugs. Diabetes mellitus was deﬁned as a fasting glu-
cose concentration of N7.0 mmol/L or the use of antidiabetic therapy.
2.2. BMI
Weight was measured with the patient wearing indoor clothing
and height was measured without shoes. BMI was calculated by
dividing the patient's weight (in kg) by the square of the heightunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cation of BMI [8,9], the patients were classiﬁed into four groups:
underweight (b18.5 kg/m2), normal weight (18.5–24.9 kg/m2),
overweight (25–29.9 kg/m2) and obese (≥30 kg/m2).
2.3. ECG
A standard 12-lead ECG was recorded at a paper speed of 25 mm/s
and an ampliﬁcation of 10mm/mV in the postprandial state and supine.
Heart rate, QRS duration, frontal plane QRS axis, and R-wave and
S-wave heights in all leads were automatically measured. Sokolow–
Lyon index, whichwas commonly used for detecting LVH, was calculat-
ed as SV1 + RV5 (mm) [10].
2.4. Echocardiography
In 160 of the 203 patients, echocardiographic assessment was con-
ducted on the same day of ECG by three experienced sonographers,
who had no knowledge of the clinical data, using high-quality commer-
cially available ultrasound systemswith 3.5MHz probes (GE Healthcare
Vivid 7, Milwaukee, WI; TOSHIBA Medical Artida, Tokyo). Echocardio-
graphic studies were performed in the morning after 30 min rest with
the subject in a supine left lateral decubitus position. Interventricular
septal thickness (IVS), posterior wall thickness (PWT) and left ventricu-
lar internal dimension (LVID) were measured at end-diastole according
to established standards of the American Society of Echocardiography
(ASE). Left ventricular ejection fraction was obtained using a modiﬁed
biplane Simpson's method from the apical 2- and 4-chamber views.
LVM was calculated according to the ASE-recommended formula [11]:
LVM gð Þ ¼ 0:8 1:04 IVSþ LVIDþ PWTð Þ3‐ LVIDð Þ3
h in o
þ 0:6:
Relative wall thickness (RWT) was calculated as using the formula:
RWT ¼ 2 PWTð Þ=LVID:
To evaluate how Sokolow–Lyon index (in mm) reﬂect LVM (in g) in
each group, Sokolow–Lyon index was divided by LVM.
2.5. Statistical analysis
Continuous variables are shown as mean ± SD, and categorical var-
iables are presented as frequencies and percentages. Continuous vari-
ables were compared by Kruskal–Wallis test. Categorical variables
were compared by chi-square test or Fisher's exact test. CorrelationTable 1
Patient characteristics.
Underweight (n = 18) Normal weight (
Age (years) 70.7 ± 14.5 71.5 ± 11.5
Male 8 (44.4%) 61 (60.4%)
Height (cm) 159.4 ± 10.5 159.8 ± 9.3
Weight (kg) 43.1 ± 7.2 56.6 ± 7.6
BMI (kg/m2) 16.8 ± 1.3 22.1 ± 1.8
Hypertension 2 (11.1%) 67 (66.3%)
Diabetes 1 (5.6%) 15 (14.9%)
Electrocardiogram
Heart rate (bpm) 64.5 ± 8.4 66.3 ± 10.7
QRS duration (msec) 90.1 ± 8.6 89.8 ± 9.3
QRS axis (degree) 70.9 ± 13.8 39.9 ± 25.0
Sokolow–Lyon index (mm) 24.7 ± 6.8 27.2 ± 7.6
Echocardiogram (n = 12) (n = 83)
LVID (mm) 42.8 ± 4.7 47.1 ± 4.1
RWT 0.39 ± 0.06 0.38 ± 0.05
Ejection fraction (%) 63.7 ± 8.4 63.2 ± 5.3
LVM (g) 112.0 ± 28.1 141.1 ± 30.9
BMI, body mass index; LVID, left ventricular internal dimension; RWT, relative wall thickness;between BMI and QRS axis was assessed by Pearson's correlation test.
Multivariate linear regression analysis was performed among age,
female, BMI, hypertension, LVID and LVM to determine factors asso-
ciated with QRS axis. The ability of RaVF divided by RI (RaVF / RI) to
discriminate between the underweight or obese and other groups
was evaluated by receiver operating characteristic (ROC) curve anal-
yses. Differences were considered signiﬁcant if the p value was
b0.05. Statistical analysis was conducted using JMP 11 software
(SAS Institute, Tokyo, Japan).
3. Results
3.1. Patient characteristics
The 4 groups compromised: underweight, 18 patients; normal
weight, 101 patients; overweight, 50 patients; and obese, 34 patients.
Patient characteristics are shown in Table 1. Obese patients were signif-
icantly younger than those in other groups. With increasing BMI, the
incidences of hypertension (p b 0.0001) and diabetes mellitus (p =
0.027) increased.
3.2. Effects of BMI on QRS axis
With increasing BMI, heart rate increased. There was no signiﬁcant
difference in QRS duration among the four groups. QRS axis was
70.9 ± 13.8° in the underweight, 39.9 ± 25.0° in the normal weight,
23.4 ± 24.1° in the overweight and 2.0 ± 26.1° in the obese (Fig. 1).
With increasing BMI, QRS axis shifted rightward to leftward. There
was a signiﬁcant inverse correlation between BMI and QRS axis
(r=−0.60, p b 0.0001) (Fig. 2). A multivariate linear regression analy-
sis including age, female, BMI, hypertension, LVID and LVM was per-
formed in 160 patients undergoing both ECG and echocardiography,
and revealed that BMI was an independent determinant of QRS axis
(β=−0.52, p b 0.0001) (Table 2).
3.3. Effects of BMI on R-wave heights
In limb leads, with increasing BMI, R-wave heights in leads I and aVL
increased, and R-wave heights in leads II, III and aVF decreased (Fig. 3).
ROC curve analyses showed that RaVF / RI signiﬁcantly discriminated
between the underweight and other groups, with an area under the
curve of 0.94 (p b 0.0001) (Fig. 4, left panel). RaVF / RI of 2.13 was the
optimal cutoff value for predicting lean, with a sensitivity of 83.3% and
a speciﬁcity of 91.4%. Also, RaVF / RI signiﬁcantly discriminated between
the obese and other groups, with an area under the curve of 0.82 (p b
0.0001) (Fig. 4, right panel). RaVF / RI of 0.62 was the optimal cutoffn = 101) Overweight (n = 50) Obese (n = 34) p value
69.1 ± 11.0 59.1 ± 12.1 b0.0001
35 (70.0%) 22 (64.7%) 0.27
162.3 ± 9.5 161.8 ± 8.3 0.31
70.7 ± 9.7 87.8 ± 11.3 b0.0001
26.7 ± 1.3 33.5 ± 2.8 b0.0001
39 (78.0%) 26 (82.4%) b0.0001
11 (22.0%) 12 (35.3%) 0.027
66.7 ± 12.0 72.8 ± 13.1 0.043
91.5 ± 10.1 92.3 ± 10.4 0.65
23.4 ± 24.1 2.0 ± 26.1 b0.0001
25.5 ± 6.9 23.9 ± 7.5 0.091
(n = 40) (n = 25)
49.0 ± 4.5 50.0 ± 5.9 b0.0001
0.37 ± 0.05 0.41 ± 0.08 0.34
62.3 ± 5.2 60.7 ± 7.1 0.13
160.7 ± 34.7 181.5 ± 47.1 b0.0001
LVM, left ventricular mass.
Fig. 1. Electrocardiograms in the underweight (right panel) and obese (right panel).
Fig. 2. There was a signiﬁcant inverse correlation between bodymass index and QRS axis.
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ity of 60.4%.
In precordial leads, R-wave heights in leads V1-2 and V6 did not
differ among the four groups (Fig. 2). Although LVM increased with in-
creasing BMI (Table 1), R-wave heights in leads V4-5 were similar
among the underweight, normal weight and overweight. R-wave
heights in leads V4-5 were signiﬁcantly lower paradoxically in the
obese than other groups. Consequently, Sokolow–Lyon index tended
to be lower paradoxically in the obese than other groups. Sokolow–
Lyon index corrected by LVM was assessed in 160 patients undergoing
both ECG and echocardiography. With increasing BMI, Sokolow–Lyon
index corrected by LVM decreased progressively (Fig. 5). In all groups,Table 2
Multivariate linear regression analysis for QRS axis.
Variable β p value
Age −0.038 0.59
Female 0.11 0.12
Body mass index −0.52 b0.0001
Hypertension −0.039 0.58
LVID −0.011 0.91
LVM −0.095 0.38
R2 = 0.37, β= standardized coefﬁcient.
LVID, left ventricular internal dimension; LVM, left ventricular mass.
Fig. 3. R-wave heights in each lead on electrocardiogram. $p b 0.05, #p b 0.01, ##p b 0.001
(Kruskal–Wallis tests).
Fig. 5. Sokolow–Lyon index corrected by left ventricularmasswas assessed in 160 patients
undergoing both electrocardiogram and echocardiography. With increasing body mass
index, Sokolow–Lyon index corrected by left ventricular mass decreased progressively.
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LVM between patients with hypertension and those without (Table 3).
4. Discussion
In the present study, we demonstrated the following: 1) with in-
creasing BMI, QRS axis shifted rightward to leftward, and BMIwas an in-
dependent determinant of QRS axis; 2) R-wave heights in leads V4-5
were similar among the underweight, normal weight and overweight,
and were signiﬁcantly lower paradoxically in the obese than other
groups; and 3) with increasing BMI, Sokolow–Lyon index corrected by
LVM decreased progressively.
Previous studies have assessed ECG in the obese. Eisenstein et al.
reported QRS axis was more leftward in the obese (N50 lb + ideal
weight) than in the normal weight [3]. Alpert et al. also showed similar
results in normotensive obese patients (Ntwice the ideal weight) com-
pared to healthy normotensive subjects [4]. These studies assessed
ECGs in variable degrees of the obese, and did not include the under-
weight opposite to the obese. Furthermore, it remained to be investigat-
ed whether leftward shift of QRS axis in the obese was based on
increased BMI or LVH because detailed echocardiographic assessments
were lacking. In the present study, we included the underweight as
well as the obese, and showed that QRS axis shifted rightward to left-
ward progressively with increasing BMI. Indeed, patients with higherFig. 4. Receiver operating characteristic curve analyses for RaVF / RIBMI had more frequent hypertension and larger LVM. However, multi-
variate analysis including both variables showed that BMI was an inde-
pendent determinant of QRS axis, but LVM was not. Our results
suggested that rightward shift of QRS in the underweight and leftward
shift in the obese were mainly based on increased BMI. Leftward shift
of QRS axis in the obese is possibly explained by an upward shift of
the diaphragm and a more horizontal anatomic position of the heart
due to abdominal adiposity.
Low QRS voltage has been shown as an ECG abnormality associated
with the obese. Rautaharju et al. showed that RV5 was consistently
lower in overweight men (N27 kg/m2) and women (N25 kg/m2)
compared to men and women with normal weight [5]. Lavie et al. re-
vealed that Sokolow–Lyon index was lower in the obese (N150% of
ideal weight) than in the underweight (b105% of ideal weight) [6]. On
the other hand, Alpert et al. reported that the incidence of Sokolow–
Lyon index N35 mm was signiﬁcantly higher in the obese (Ntwice the
ideal weight) compared to normal weight [4]. These results were con-
fused because these studies did not include echocardiographic assess-
ments or did not evaluate how ECG voltages reﬂected LVM in each
group. Thus, the systematic evaluation of this variable remains to beto predict the underweight (right panel) and obese (left panel).
Table 3
Effects of hypertension on Sokolow–Lyon index corrected by left ventricular mass.
Underweight Normal weight Overweight Obese
Hypertension Hypertension Hypertension Hypertension
Present
(n = 2)
Absent
(n = 10)
Present
(n = 53)
Absent
(n = 30)
Present
(n = 33)
Absent
(n = 7)
Present
(n = 20)
Absent
(n = 5)
BMI (kg/m2) 16.0 ± 2.7 16.8 ± 0.9 22.4 ± 1.7 21.4 ± 1.8$ 26.9 ± 1.4 26.0 ± 1.1 33.9 ± 3.2 34.1 ± 2.8
Sokolow–Lyon index (mm) 27.4 ± 3.0 26.7 ± 6.9 27.7 ± 7.6 24.5 ± 7.4 25.5 ± 7.9 26.5 ± 5.0 23.6 ± 7.5 21.1 ± 9.4
LVM (g) 96.0 ± 19.3 115.2 ± 29.3 149.0 ± 27.9 127.3 ± 31.5# 165.4 ± 34.3 138.6 ± 28.9 184.3 ± 47.1 170.3 ± 50.6
Sokolow–Lyon index/LVM (mm/g) 0.29 ± 0.09 0.24 ± 0.05 0.19 ± 0.06 0.20 ± 0.06 0.16 ± 0.05 0.20 ± 0.05 0.14 ± 0.05 0.12 ± 0.02
BMI, body mass index; LVM, left ventricular mass.
$ p b 0.05.
# p b 0.01.
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leads in each group, and demonstrated that RV4 and RV5 were similar
among the underweight, normal weight and overweight, and were sig-
niﬁcantly lower in the obese than other groups. Because LVM increased
with increasing BMI, original ECG voltages should increase. Recorded
ECG voltages are determined by the balance between original ECG volt-
ages from left ventricle and the attenuation through chestwall [12]. The
thickened and adiposity-laden chest wall in the overweight would
attenuate original ECG voltages resulting in similar recorded ECG voltages
between the normal weight and overweight. Muchmore adiposity in the
obese would attenuate original ECG voltages markedly resulting in lower
recording ECG voltages than in normal weight. These explanations are
supported by the fact that Sokolow–Lyon indexunderestimated LVMpro-
gressively with increasing BMI as shown in the present study.
There were several limitations in this study. First, among the four
groups, there were signiﬁcant differences in hypertension and LVM
that could be associated with leftward shift of QRS axis. However, it is
noteworthy that BMI was an independent determinant of QRS axis,
but these were not in multivariate analysis. Second, we did not assess
the distance between the left ventricle and the electrode that would
be associated with R-wave heights. Third, we did not have serial ECG
data concerning weight gain or loss [13]. Forth, we excluded patients
with strain pattern suggesting marked LVH. Further studies are neces-
sary to clarify whether our ﬁndings are applicable to these patients.
Finally, the small sample size is a major limitation of this study.
In conclusion, the underweight or obese is strongly associated with
QRS axis or R-wave heights. Our results suggest that BMI should be
taken into consideration especially when assessing LVH on ECG.Conﬂict of interest
The authors declare that they have no conﬂict of interest.References
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